South East Asian organisations risk losing over three quarters of their talent

Pharma, biotech and medical devices organisations across South East Asia are at risk of losing over three quarters of their best people in the year ahead, according to a new report published by Real.

Read more ...

Real and Teva UK: Addressing Gen Y

Real has partnered with Teva UK to help address the challenges of recruiting and retaining Generation Y employees and to help them be more competitive in the increasingly demanding recruitment market.

Read more ...

Novartis COPD drug is backed by EU for approval

Swiss pharma giant Novartis is a step closer to winning European approval for its new chronic obstructive pulmonary disorder (COPD) therapy drug, Ultibro Breezhaler, after an endorsement by the European Committee for Medicinal Products for Human Use (CHMP).

Read more ...

NICE offers ground-breaking treatment in the fight against breast cancer

Under ground- breaking new guidance from NICE, the National Institute for Health and Care Excellence, thousands of women across England and Wales with a family history of breast cancer are being given access to medicines to help cut the risk of breast cancer by up to 40%.

Read more ...